MYUNGMOON Pharm co.,Ltd (KOSE:A017180) announces a share repurchase program. Under the program, the company will repurchase up to KRW 300 million worth of its shares, pursuant to a trust contract with DAISHIN Securities Co., LTD. The purpose of the program is to stabilize stock price and uplift the value of shareholders. The program will expire on January 9, 2025.

As of July 9, 2024, the company had no shares in treasury within scope available for dividend and had 426,256 shares in treasury under other capacities.